You are here

  • Home
  • Archive
  • Volume 72, Issue 12
  • Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study

Article metrics

Article menu

Download PDFPDF

Short report
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study

 

Online download statistics by month:

Online download statistics by month: June 2019 to March 2025

AbstractFullPdf
Jun 201919220323
Jul 201938142362
Aug 201936936412
Sep 201935634721
Oct 201920619927
Nov 201914714235
Dec 201910310265
Jan 2020716535
Feb 2020838035
Mar 2020554918
Apr 2020474625
May 2020494611
Jun 2020777030
Jul 2020747219
Aug 2020646311
Sep 2020444211
Oct 202040396
Nov 2020282411
Dec 2020363210
Jan 2021403819
Feb 2021292911
Mar 2021494915
Apr 2021616020
May 202152519
Jun 202160608
Jul 2021494910
Aug 2021545415
Sep 2021484822
Oct 2021383723
Nov 2021393620
Dec 202126267
Jan 2022222020
Feb 202217175
Mar 2022191915
Apr 2022222110
May 2022323112
Jun 202230299
Jul 202226243
Aug 202230305
Sep 2022383432
Oct 2022565613
Nov 2022191712
Dec 202212111
Jan 202318187
Feb 2023373711
Mar 202312128
Apr 2023101010
May 2023987
Jun 20231097
Jul 202310911
Aug 202316165
Sep 202310104
Oct 202315161
Nov 2023262613
Dec 2023181810
Jan 2024141413
Feb 202415159
Mar 2024111141
Apr 2024131316
May 2024232111
Jun 2024191811
Jul 2024151518
Aug 202420195
Sep 202414136
Oct 2024757651
Nov 2024585714
Dec 2024666711
Jan 202519198
Feb 2025545117
Mar 2025383821
Total393538901129